128 related articles for article (PubMed ID: 36152731)
1. CD93 promotes acute myeloid leukemia development and is a potential therapeutic target.
Jia J; Liu B; Wang D; Wang X; Song L; Ren Y; Guo Z; Ma K; Cui C
Exp Cell Res; 2022 Nov; 420(2):113361. PubMed ID: 36152731
[TBL] [Abstract][Full Text] [Related]
2. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.
Iwasaki M; Liedtke M; Gentles AJ; Cleary ML
Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756
[TBL] [Abstract][Full Text] [Related]
3. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
[TBL] [Abstract][Full Text] [Related]
4. NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity.
Richards RM; Zhao F; Freitas KA; Parker KR; Xu P; Fan A; Sotillo E; Daugaard M; Oo HZ; Liu J; Hong WJ; Sorensen PH; Chang HY; Satpathy AT; Majzner RG; Majeti R; Mackall CL
Blood Cancer Discov; 2021 Nov; 2(6):648-665. PubMed ID: 34778803
[TBL] [Abstract][Full Text] [Related]
5. CD93 a potential player in cytotrophoblast and endothelial cell migration.
Fantone S; Tossetta G; Di Simone N; Tersigni C; Scambia G; Marcheggiani F; Giannubilo SR; Marzioni D
Cell Tissue Res; 2022 Jan; 387(1):123-130. PubMed ID: 34674045
[TBL] [Abstract][Full Text] [Related]
6. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.
Lugano R; Vemuri K; Yu D; Bergqvist M; Smits A; Essand M; Johansson S; Dejana E; Dimberg A
J Clin Invest; 2018 Aug; 128(8):3280-3297. PubMed ID: 29763414
[TBL] [Abstract][Full Text] [Related]
7. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA.
Nativel B; Ramin-Mangata S; Mevizou R; Figuester A; Andries J; Iwema T; Ikewaki N; Gasque P; Viranaïcken W
Immunology; 2019 Oct; 158(2):85-93. PubMed ID: 31335975
[TBL] [Abstract][Full Text] [Related]
8. Regulation of CD93 cell surface expression by protein kinase C isoenzymes.
Ikewaki N; Kulski JK; Inoko H
Microbiol Immunol; 2006; 50(2):93-103. PubMed ID: 16490927
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of the C-type lectin CD93 in the glioblastoma vasculature regulates cytoskeletal rearrangements that enhance vessel function and reduce host survival.
Langenkamp E; Zhang L; Lugano R; Huang H; Elhassan TE; Georganaki M; Bazzar W; Lööf J; Trendelenburg G; Essand M; Pontén F; Smits A; Dimberg A
Cancer Res; 2015 Nov; 75(21):4504-16. PubMed ID: 26363010
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood.
Ikewaki N; Yamao H; Kulski JK; Inoko H
J Clin Immunol; 2010 Sep; 30(5):723-33. PubMed ID: 20512406
[TBL] [Abstract][Full Text] [Related]
11. CD93 is rapidly shed from the surface of human myeloid cells and the soluble form is detected in human plasma.
Bohlson SS; Silva R; Fonseca MI; Tenner AJ
J Immunol; 2005 Jul; 175(2):1239-47. PubMed ID: 16002728
[TBL] [Abstract][Full Text] [Related]
12. Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells.
Barbera S; Raucci L; Tassone G; Tinti L; Prischi F; Santucci A; Mongiat M; Tosi GM; Galvagni F; Dimberg A; Pozzi C; Orlandini M
Int J Biol Macromol; 2023 Jan; 224():453-464. PubMed ID: 36265539
[TBL] [Abstract][Full Text] [Related]
13. Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression.
Zhang D; Guo Y; Zhao Y; Yu L; Chang Z; Pei H; Huang J; Chen C; Xue H; Xu X; Pan Y; Li N; Zhu C; Zhao ZJ; Yu J; Chen Y
Microb Cell Fact; 2021 Mar; 20(1):67. PubMed ID: 33691697
[TBL] [Abstract][Full Text] [Related]
14. The epidermal growth factor-like domain of CD93 is a potent angiogenic factor.
Kao YC; Jiang SJ; Pan WA; Wang KC; Chen PK; Wei HJ; Chen WS; Chang BI; Shi GY; Wu HL
PLoS One; 2012; 7(12):e51647. PubMed ID: 23272129
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.
Bao L; Tang M; Zhang Q; You B; Shan Y; Shi S; Li L; Hu S; You Y
Biochem Biophys Res Commun; 2016 Aug; 476(4):467-474. PubMed ID: 27255994
[TBL] [Abstract][Full Text] [Related]
16. Soluble expression of disulfide-bonded C-type lectin like domain of human CD93 in the cytoplasm of Escherichia coli.
Nativel B; Figuester A; Andries J; Planesse C; Couprie J; Gasque P; Viranaicken W; Iwema T
J Immunol Methods; 2016 Dec; 439():67-73. PubMed ID: 27742562
[TBL] [Abstract][Full Text] [Related]
17. CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis.
Griffiths MR; Botto M; Morgan BP; Neal JW; Gasque P
Immunology; 2018 Nov; 155(3):346-355. PubMed ID: 29923617
[TBL] [Abstract][Full Text] [Related]
18. CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration adhesion and migration.
Galvagni F; Nardi F; Maida M; Bernardini G; Vannuccini S; Petraglia F; Santucci A; Orlandini M
Oncotarget; 2016 Mar; 7(9):10090-103. PubMed ID: 26848865
[TBL] [Abstract][Full Text] [Related]
19. LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia.
Anami Y; Deng M; Gui X; Yamaguchi A; Yamazaki CM; Zhang N; Zhang CC; An Z; Tsuchikama K
Mol Cancer Ther; 2020 Nov; 19(11):2330-2339. PubMed ID: 32879051
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD93 Is Involved in Metabolic Dysregulation but Does Not Influence Carotid Intima-Media Thickness.
Strawbridge RJ; Hilding A; Silveira A; Österholm C; Sennblad B; McLeod O; Tsikrika P; Foroogh F; Tremoli E; Baldassarre D; Veglia F; Rauramaa R; Smit AJ; Giral P; Kurl S; Mannarino E; Grossi E; Syvänen AC; Humphries SE; de Faire U; Östenson CG; Maegdefessel L; Hamsten A; Bäcklund A;
Diabetes; 2016 Oct; 65(10):2888-99. PubMed ID: 27659228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
